Next Generation Sequencing (NGS) Market, Global Outlook and Forecast 2024-2030
Report ID
47276
Publisher
Market Monitor Global
Published Date
07-Feb
Delivery Format
PDF
No of Report Page
148
Editor's Rating
US $3,250.00
US $4,225.00
US $4,875.00
  • Report Details 
    This research report provides a comprehensive analysis of the Next Generation Sequencing (NGS) market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Next Generation Sequencing (NGS) market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Next Generation Sequencing (NGS), challenges faced by the industry, and potential opportunities for market players.

The global Next Generation Sequencing (NGS) market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Next Generation Sequencing (NGS) market presents opportunities for various stakeholders, including Academic & Government Research Institutes, Pharmaceutical Companies. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Next Generation Sequencing (NGS) market. Additionally, the growing consumer demand present avenues for market expansion.

The global Next Generation Sequencing (NGS) market was valued at US$ 3480.5 million in 2023 and is projected to reach US$ 4466.3 million by 2030, at a CAGR of 3.6% during the forecast period.

The classification of Next-Generation Sequencing (NGS) Services includes Targeted Sequencing, Whole Exome Sequencing and Whole Genome Sequencing, and the proportion of Targeted Sequencing in 2019 is about 55%.

Next-Generation Sequencing (NGS) Services is widely used in Hospitals and Clinics, Biopharma Companies, Academic & Research Organizations and Other. The most proportion of Next-Generation Sequencing (NGS) Services is Hospitals and Clinics, and the proportion in 2019 is about 56%.

North America is the largest consumption place, with a consumption market share nearly 37% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of about 32%.

Eurofins Scientific, Natera, BGI, Illumina, etc. are the leaders of the industry.

Key Features:
The research report on the Next Generation Sequencing (NGS) market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.

Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Next Generation Sequencing (NGS) market.

Market Overview: The report provides a comprehensive overview of the Next Generation Sequencing (NGS) market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Targeted Sequencing, Whole Exome Sequencing), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.

Market Dynamics: The report analyses the market dynamics driving the growth and development of the Next Generation Sequencing (NGS) market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Next Generation Sequencing (NGS) market's trajectory.

Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Next Generation Sequencing (NGS) market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.

Market Segmentation and Forecast: The report segment the Next Generation Sequencing (NGS) market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.

Technological Trends: The report should highlight the key technological trends shaping the Next Generation Sequencing (NGS) market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.

Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Next Generation Sequencing (NGS) market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.

Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Next Generation Sequencing (NGS), including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.

Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Next Generation Sequencing (NGS) market.

Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.

Market Segmentation
Next Generation Sequencing (NGS) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type

      
 	
    • Targeted Sequencing
      • 
 	
    • Whole Exome Sequencing
      • 
 	
    • Whole Genome Sequencing
      • 

    
Market segment by Application

      
 	
    • Academic & Government Research Institutes
      • 
 	
    • Pharmaceutical Companies
      • 
 	
    • Biotechnology Companies
      • 
 	
    • Hospitals & Clinics
      • 

    
By Region

Global Next Generation Sequencing (NGS) Market Segment Percentages, By Region and Country, 2023 (%)

North America

      
 	
    • US
      • 
 	
    • Canada
      • 
 	
    • Mexico
      • 

    
Europe

      
 	
    • Germany
      • 
 	
    • France
      • 
 	
    • U.K.
      • 
 	
    • Italy
      • 
 	
    • Russia
      • 
 	
    • Nordic Countries
      • 
 	
    • Benelux
      • 
 	
    • Rest of Europe
      • 

    
Asia

      
 	
    • China
      • 
 	
    • Japan
      • 
 	
    • South Korea
      • 
 	
    • Southeast Asia
      • 
 	
    • India
      • 
 	
    • Rest of Asia
      • 

    
South America

      
 	
    • Brazil
      • 
 	
    • Argentina
      • 
 	
    • Rest of South America
      • 

    
Middle East & Africa

      
 	
    • Turkey
      • 
 	
    • Israel
      • 
 	
    • Saudi Arabia
      • 
 	
    • UAE
      • 
 	
    • Rest of Middle East & Africa
      • 

    
Major players covered

      
 	
    • Illumina
      • 
 	
    • Thermo Fisher Scientific
      • 
 	
    • Pacific Biosciences of California
      • 
 	
    • Beijing Genomics Institute
      • 
 	
    • Qiagen
      • 
 	
    • Roche
      • 
 	
    • Agilent Technologies
      • 
 	
    • Perkinelmer
      • 
 	
    • Genomatix
      • 
 	
    • PierianDx
      • 
 	
    • Eurofins Scientific
      • 
 	
    • Gatc Biotech
      • 
 	
    • Oxford Nanopore Technologies
      • 
 	
    • Bio-Rad Laboratories
      • 
 	
    • DNASTAR
      • 
 	
    • Biomatters
      • 
 	
    • Partek
      • 
 	
    • New England Biolabs
      • 
 	
    • Myriad Genetics
      • 
 	
    • Macrogen
      • 

    
Outline of Major Chapters:
Chapter 1: Introduces the definition of Next Generation Sequencing (NGS), market overview.

Chapter 2: Global Next Generation Sequencing (NGS) market size in revenue.

Chapter 3: Detailed analysis of Next Generation Sequencing (NGS) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Next Generation Sequencing (NGS) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: The main points and conclusions of the report.
  • Table Of Content 
    1 Introduction to Research & Analysis Reports
1.1 Next Generation Sequencing (NGS) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Next Generation Sequencing (NGS) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Next Generation Sequencing (NGS) Overall Market Size
2.1 Global Next Generation Sequencing (NGS) Market Size: 2023 VS 2030
2.2 Global Next Generation Sequencing (NGS) Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Next Generation Sequencing (NGS) Players in Global Market
3.2 Top Global Next Generation Sequencing (NGS) Companies Ranked by Revenue
3.3 Global Next Generation Sequencing (NGS) Revenue by Companies
3.4 Top 3 and Top 5 Next Generation Sequencing (NGS) Companies in Global Market, by Revenue in 2023
3.5 Global Companies Next Generation Sequencing (NGS) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Next Generation Sequencing (NGS) Players in Global Market
3.6.1 List of Global Tier 1 Next Generation Sequencing (NGS) Companies
3.6.2 List of Global Tier 2 and Tier 3 Next Generation Sequencing (NGS) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Next Generation Sequencing (NGS) Market Size Markets, 2023 & 2030
4.1.2 Targeted Sequencing
4.1.3 Whole Exome Sequencing
4.1.4 Whole Genome Sequencing
4.2 By Type - Global Next Generation Sequencing (NGS) Revenue & Forecasts
4.2.1 By Type - Global Next Generation Sequencing (NGS) Revenue, 2019-2024
4.2.2 By Type - Global Next Generation Sequencing (NGS) Revenue, 2025-2030
4.2.3 By Type - Global Next Generation Sequencing (NGS) Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Next Generation Sequencing (NGS) Market Size, 2023 & 2030
5.1.2 Academic & Government Research Institutes
5.1.3 Pharmaceutical Companies
5.1.4 Biotechnology Companies
5.1.5 Hospitals & Clinics
5.2 By Application - Global Next Generation Sequencing (NGS) Revenue & Forecasts
5.2.1 By Application - Global Next Generation Sequencing (NGS) Revenue, 2019-2024
5.2.2 By Application - Global Next Generation Sequencing (NGS) Revenue, 2025-2030
5.2.3 By Application - Global Next Generation Sequencing (NGS) Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Next Generation Sequencing (NGS) Market Size, 2023 & 2030
6.2 By Region - Global Next Generation Sequencing (NGS) Revenue & Forecasts
6.2.1 By Region - Global Next Generation Sequencing (NGS) Revenue, 2019-2024
6.2.2 By Region - Global Next Generation Sequencing (NGS) Revenue, 2025-2030
6.2.3 By Region - Global Next Generation Sequencing (NGS) Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Next Generation Sequencing (NGS) Revenue, 2019-2030
6.3.2 US Next Generation Sequencing (NGS) Market Size, 2019-2030
6.3.3 Canada Next Generation Sequencing (NGS) Market Size, 2019-2030
6.3.4 Mexico Next Generation Sequencing (NGS) Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Next Generation Sequencing (NGS) Revenue, 2019-2030
6.4.2 Germany Next Generation Sequencing (NGS) Market Size, 2019-2030
6.4.3 France Next Generation Sequencing (NGS) Market Size, 2019-2030
6.4.4 U.K. Next Generation Sequencing (NGS) Market Size, 2019-2030
6.4.5 Italy Next Generation Sequencing (NGS) Market Size, 2019-2030
6.4.6 Russia Next Generation Sequencing (NGS) Market Size, 2019-2030
6.4.7 Nordic Countries Next Generation Sequencing (NGS) Market Size, 2019-2030
6.4.8 Benelux Next Generation Sequencing (NGS) Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Next Generation Sequencing (NGS) Revenue, 2019-2030
6.5.2 China Next Generation Sequencing (NGS) Market Size, 2019-2030
6.5.3 Japan Next Generation Sequencing (NGS) Market Size, 2019-2030
6.5.4 South Korea Next Generation Sequencing (NGS) Market Size, 2019-2030
6.5.5 Southeast Asia Next Generation Sequencing (NGS) Market Size, 2019-2030
6.5.6 India Next Generation Sequencing (NGS) Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Next Generation Sequencing (NGS) Revenue, 2019-2030
6.6.2 Brazil Next Generation Sequencing (NGS) Market Size, 2019-2030
6.6.3 Argentina Next Generation Sequencing (NGS) Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Next Generation Sequencing (NGS) Revenue, 2019-2030
6.7.2 Turkey Next Generation Sequencing (NGS) Market Size, 2019-2030
6.7.3 Israel Next Generation Sequencing (NGS) Market Size, 2019-2030
6.7.4 Saudi Arabia Next Generation Sequencing (NGS) Market Size, 2019-2030
6.7.5 UAE Next Generation Sequencing (NGS) Market Size, 2019-2030
7 Next Generation Sequencing (NGS) Companies Profiles
7.1 Illumina
7.1.1 Illumina Company Summary
7.1.2 Illumina Business Overview
7.1.3 Illumina Next Generation Sequencing (NGS) Major Product Offerings
7.1.4 Illumina Next Generation Sequencing (NGS) Revenue in Global Market (2019-2024)
7.1.5 Illumina Key News & Latest Developments
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Company Summary
7.2.2 Thermo Fisher Scientific Business Overview
7.2.3 Thermo Fisher Scientific Next Generation Sequencing (NGS) Major Product Offerings
7.2.4 Thermo Fisher Scientific Next Generation Sequencing (NGS) Revenue in Global Market (2019-2024)
7.2.5 Thermo Fisher Scientific Key News & Latest Developments
7.3 Pacific Biosciences of California
7.3.1 Pacific Biosciences of California Company Summary
7.3.2 Pacific Biosciences of California Business Overview
7.3.3 Pacific Biosciences of California Next Generation Sequencing (NGS) Major Product Offerings
7.3.4 Pacific Biosciences of California Next Generation Sequencing (NGS) Revenue in Global Market (2019-2024)
7.3.5 Pacific Biosciences of California Key News & Latest Developments
7.4 Beijing Genomics Institute
7.4.1 Beijing Genomics Institute Company Summary
7.4.2 Beijing Genomics Institute Business Overview
7.4.3 Beijing Genomics Institute Next Generation Sequencing (NGS) Major Product Offerings
7.4.4 Beijing Genomics Institute Next Generation Sequencing (NGS) Revenue in Global Market (2019-2024)
7.4.5 Beijing Genomics Institute Key News & Latest Developments
7.5 Qiagen
7.5.1 Qiagen Company Summary
7.5.2 Qiagen Business Overview
7.5.3 Qiagen Next Generation Sequencing (NGS) Major Product Offerings
7.5.4 Qiagen Next Generation Sequencing (NGS) Revenue in Global Market (2019-2024)
7.5.5 Qiagen Key News & Latest Developments
7.6 Roche
7.6.1 Roche Company Summary
7.6.2 Roche Business Overview
7.6.3 Roche Next Generation Sequencing (NGS) Major Product Offerings
7.6.4 Roche Next Generation Sequencing (NGS) Revenue in Global Market (2019-2024)
7.6.5 Roche Key News & Latest Developments
7.7 Agilent Technologies
7.7.1 Agilent Technologies Company Summary
7.7.2 Agilent Technologies Business Overview
7.7.3 Agilent Technologies Next Generation Sequencing (NGS) Major Product Offerings
7.7.4 Agilent Technologies Next Generation Sequencing (NGS) Revenue in Global Market (2019-2024)
7.7.5 Agilent Technologies Key News & Latest Developments
7.8 Perkinelmer
7.8.1 Perkinelmer Company Summary
7.8.2 Perkinelmer Business Overview
7.8.3 Perkinelmer Next Generation Sequencing (NGS) Major Product Offerings
7.8.4 Perkinelmer Next Generation Sequencing (NGS) Revenue in Global Market (2019-2024)
7.8.5 Perkinelmer Key News & Latest Developments
7.9 Genomatix
7.9.1 Genomatix Company Summary
7.9.2 Genomatix Business Overview
7.9.3 Genomatix Next Generation Sequencing (NGS) Major Product Offerings
7.9.4 Genomatix Next Generation Sequencing (NGS) Revenue in Global Market (2019-2024)
7.9.5 Genomatix Key News & Latest Developments
7.10 PierianDx
7.10.1 PierianDx Company Summary
7.10.2 PierianDx Business Overview
7.10.3 PierianDx Next Generation Sequencing (NGS) Major Product Offerings
7.10.4 PierianDx Next Generation Sequencing (NGS) Revenue in Global Market (2019-2024)
7.10.5 PierianDx Key News & Latest Developments
7.11 Eurofins Scientific
7.11.1 Eurofins Scientific Company Summary
7.11.2 Eurofins Scientific Business Overview
7.11.3 Eurofins Scientific Next Generation Sequencing (NGS) Major Product Offerings
7.11.4 Eurofins Scientific Next Generation Sequencing (NGS) Revenue in Global Market (2019-2024)
7.11.5 Eurofins Scientific Key News & Latest Developments
7.12 Gatc Biotech
7.12.1 Gatc Biotech Company Summary
7.12.2 Gatc Biotech Business Overview
7.12.3 Gatc Biotech Next Generation Sequencing (NGS) Major Product Offerings
7.12.4 Gatc Biotech Next Generation Sequencing (NGS) Revenue in Global Market (2019-2024)
7.12.5 Gatc Biotech Key News & Latest Developments
7.13 Oxford Nanopore Technologies
7.13.1 Oxford Nanopore Technologies Company Summary
7.13.2 Oxford Nanopore Technologies Business Overview
7.13.3 Oxford Nanopore Technologies Next Generation Sequencing (NGS) Major Product Offerings
7.13.4 Oxford Nanopore Technologies Next Generation Sequencing (NGS) Revenue in Global Market (2019-2024)
7.13.5 Oxford Nanopore Technologies Key News & Latest Developments
7.14 Bio-Rad Laboratories
7.14.1 Bio-Rad Laboratories Company Summary
7.14.2 Bio-Rad Laboratories Business Overview
7.14.3 Bio-Rad Laboratories Next Generation Sequencing (NGS) Major Product Offerings
7.14.4 Bio-Rad Laboratories Next Generation Sequencing (NGS) Revenue in Global Market (2019-2024)
7.14.5 Bio-Rad Laboratories Key News & Latest Developments
7.15 DNASTAR
7.15.1 DNASTAR Company Summary
7.15.2 DNASTAR Business Overview
7.15.3 DNASTAR Next Generation Sequencing (NGS) Major Product Offerings
7.15.4 DNASTAR Next Generation Sequencing (NGS) Revenue in Global Market (2019-2024)
7.15.5 DNASTAR Key News & Latest Developments
7.16 Biomatters
7.16.1 Biomatters Company Summary
7.16.2 Biomatters Business Overview
7.16.3 Biomatters Next Generation Sequencing (NGS) Major Product Offerings
7.16.4 Biomatters Next Generation Sequencing (NGS) Revenue in Global Market (2019-2024)
7.16.5 Biomatters Key News & Latest Developments
7.17 Partek
7.17.1 Partek Company Summary
7.17.2 Partek Business Overview
7.17.3 Partek Next Generation Sequencing (NGS) Major Product Offerings
7.17.4 Partek Next Generation Sequencing (NGS) Revenue in Global Market (2019-2024)
7.17.5 Partek Key News & Latest Developments
7.18 New England Biolabs
7.18.1 New England Biolabs Company Summary
7.18.2 New England Biolabs Business Overview
7.18.3 New England Biolabs Next Generation Sequencing (NGS) Major Product Offerings
7.18.4 New England Biolabs Next Generation Sequencing (NGS) Revenue in Global Market (2019-2024)
7.18.5 New England Biolabs Key News & Latest Developments
7.19 Myriad Genetics
7.19.1 Myriad Genetics Company Summary
7.19.2 Myriad Genetics Business Overview
7.19.3 Myriad Genetics Next Generation Sequencing (NGS) Major Product Offerings
7.19.4 Myriad Genetics Next Generation Sequencing (NGS) Revenue in Global Market (2019-2024)
7.19.5 Myriad Genetics Key News & Latest Developments
7.20 Macrogen
7.20.1 Macrogen Company Summary
7.20.2 Macrogen Business Overview
7.20.3 Macrogen Next Generation Sequencing (NGS) Major Product Offerings
7.20.4 Macrogen Next Generation Sequencing (NGS) Revenue in Global Market (2019-2024)
7.20.5 Macrogen Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
  • Inquiry Before Buying

    Inquiry Before Buying

    Your personal details will remain secure and confidential - Privacy Policy

    WHY CHOOSE US

    Easy Access and Express Report Delivery Service
    Discover Business Growth Opportunities
    More than 10 Years Experience Employee Support
    In-depth and Comprehensive Analysis
    100+ Client Queries Handled Everyday
  • Request Sample

    Request For Sample

    Your personal details will remain secure and confidential - Privacy Policy

    WHY CHOOSE US

    Easy Access and Express Report Delivery Service
    Discover Business Growth Opportunities
    More than 10 Years Experience Employee Support
    In-depth and Comprehensive Analysis
    100+ Client Queries Handled Everyday


Our Trusted Clients
cooper.fr
koronos
waldenmedical
unioncomm.co.kr
technopathclinicaldiagnostics
toho-titanium.co.jp
straubmedical
sew-eurodrive.de
medurifarms
naperol
nvent
network.ae
petronas
saeedghodran
polyworldsys
seedplanning.co.jp
kraton
ipms.fraunhofer.de
infanttech
httpswww.castel-freres
hintoninfo
hexcel
freightways.co.nz
excelitas
Acco
aspet
brand
bmc
elevate
europ-assistance


GET IN TOUCH
Phone: +1 (415) 315-9432
Phone: +91 86698 89536
Email: inquiry@wiredrelease.com
SHORT NAVIGATION
connect with us